Operose Advisors Portfolio holdings
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$5.97M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
+$5.83M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.04M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$4.86M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$2.07M |
Top Sells
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$3.94M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.14M |
| 3 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$1.78M |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.44M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$1.33M |
Sector Composition
| 1 | Technology | 6.65% |
| 2 | Financials | 3.74% |
| 3 | Communication Services | 2.87% |
| 4 | Consumer Discretionary | 1.91% |
| 5 | Healthcare | 1.55% |
Similar funds
Operose Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Operose Advisors held 501 positions worth $429M, up 7% from $401M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Operose Advisors deployed $20M of net new capital in Q4 2025, opening 57 new positions and adding to 131 existing holdings. Its largest new stake was Dimensional US Large Cap Value ETF: 9,058 shares worth $310K.
By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 6.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $3.94M trimmed.
- Operose Advisors's largest Q4 2025 buy was Dimensional US Large Cap Value ETF: 9,058 shares worth $310K.
- Operose Advisors added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $5.97M increase.
- Operose Advisors's biggest Q4 2025 reduction was Vanguard Mid-Cap ETF, cutting an estimated $3.94M.
- Operose Advisors fully exited Synopsys in Q4 2025, selling an estimated $248K.
- Operose Advisors's ten largest holdings make up 62% of its $429M portfolio in Q4 2025.
- Operose Advisors opened 57 new positions and closed 29 in Q4 2025.
- Operose Advisors's portfolio value rose 7% quarter-over-quarter to $429M.
Based on Operose Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.